Related Experiment Video

Updated: May 20, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Posttranslational modifications of proteins in type 1 diabetes: the next step in finding the cure?

Jessica L Dunne1, Lut Overbergh, Anthony W Purcell

  • 1Juvenile Diabetes Research Foundation, New York, New York, USA. jdunne@jdrf.org

Diabetes
|July 25, 2012
PubMed

Insights

Posttranslational modification of beta-cell antigens is crucial for understanding type 1 diabetes. Researching these protein changes may reveal new diagnostic and therapeutic strategies for immune tolerance loss.

Area of Science:

  • Immunology
  • Endocrinology
  • Biochemistry

Background:

  • The role of beta-cell antigen modification in type 1 diabetes remains unclear.
  • Posttranslational modifications (PTMs) of proteins are critical in various biological processes.
  • Understanding PTMs in type 1 diabetes could offer new insights into disease mechanisms.

Purpose of the Study:

  • To explore the significance of beta-cell antigen modification in type 1 diabetes.
  • To discuss the potential of PTMs in developing novel diagnostic and therapeutic approaches.
  • To consolidate expert opinion on the role of PTMs in the loss of immune tolerance.

Main Methods:

  • Workshop discussion and consensus building among experts in type 1 diabetes and protein modification.
  • Review of existing literature on PTMs and their relevance to autoimmune diseases.
  • Identification of key research questions and future directions.

Main Results:

  • A prevailing opinion emerged that PTMs of beta-cell antigens are likely important in type 1 diabetes.
  • It was suggested that understanding these modifications could illuminate mechanisms of immune tolerance loss.
  • Attendees agreed that PTMs represent a promising area for developing new diagnostic and therapeutic strategies.

Conclusions:

  • Further research into the modification of beta-cell antigens is warranted.
  • PTMs of proteins are a critical area for investigation in type 1 diabetes.
  • Identifying the role of PTMs may lead to breakthroughs in managing type 1 diabetes.

More Related Videos

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets10:09

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...